Se2-8 Strategy of safety evaluation in development of pharmaceuticals, mainly biotechnology-derived products.(Proceedings of the 27th Annual Meeting)

スポンサーリンク

概要

• 論文の詳細を見る
• 日本トキシコロジー学会の論文
• 2000-10-31

著者

• Maki Eiji

  R&d Divison Janssen-kyowa Co. Ltd. Tokyo

• MAKI Eiji

  R&D Divison, Janssen-Kyowa Co., Ltd. Tokyo

関連論文

• Se2-8 Strategy of safety evaluation in development of pharmaceuticals, mainly biotechnology-derived products.(Proceedings of the 27th Annual Meeting)

スポンサーリンク